Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis.

ABSTRACT:

Background

BRS represent a new approach to treating coronary artery disease. Beneficial properties of BRS regarding the restoration of vasomotility after resorption make them attractive devices in CTO revascularization. However, experience in this setting is limited.

Methods

We systematically searched Medline, Scholar, and Scopus for reports of at least 9 patients with CTO undergoing BRS implantation. Patients' and procedural characteristics were summarized. The primary outcome of interest was target lesion revascularization (TLR). Pooled estimates were calculated using a random-effects meta-analysis. The study protocol was registered in PROSPERO (CRD42017069322).

Results

Thirteen reports for a total of 843 lesions with a median follow-up of 12 months (IQR 6-12) were

SUBMITTER: Polimeni A 

PROVIDER: S-EPMC6419823 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature